North America Animal Health Market Size and Forecasts 2031

Key Findings

• In North America, increasing pet ownership, livestock farming, and rising awareness of zoonotic diseases are major factors driving the animal health market.
• The shift toward premium veterinary care and preventive treatment in North America is creating demand for diagnostics, vaccines, and companion animal therapeutics.
• Government initiatives in North America supporting livestock disease management and animal welfare programs are expanding the market’s regulatory and infrastructural base.
• Growth in veterinary telemedicine and e-commerce for pet medications is transforming how animal health products are accessed in North America.
• Pharmaceutical companies in North America are investing heavily in R&D for species-specific vaccines and parasiticides to support both commercial and companion animal segments.
• Public-private collaborations in North America are strengthening disease surveillance systems, accelerating response time for outbreaks in both pets and farm animals.
• Adoption of wearable devices and data-driven tools for herd and pet health monitoring is growing across veterinary clinics and farms in North America.

North America Animal Health Market Size and Forecast

The North America Animal Health Market is projected to grow from USD 1.2 billion in 2025 to USD 2.35 billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 11.3% over the forecast period.

This growth is fueled by rising demand for preventive healthcare, increased expenditure on pet wellness, expansion of veterinary infrastructure, and government-backed livestock immunization programs across North America.

Introduction

The North America Animal Health Market covers the production, distribution, and use of pharmaceuticals, diagnostics, vaccines, feed additives, and medical devices designed for animals. These solutions address diseases and improve the overall wellbeing of both livestock and companion animals.

In North America, the market plays a vital role in food safety, public health, and economic sustainability. Livestock farmers seek disease control and productivity-enhancing solutions, while pet owners demand high-quality care for their animals. The convergence of veterinary science, biotechnology, and digital tools is reshaping how healthcare is delivered to animals across species and settings.

North America Animal Health Market Trends

• Growth of Companion Animal Care and Pet Insurance
  Pet humanization in North America has led to increased spending on wellness products, diagnostics, and elective surgeries. The rise of pet insurance plans is making advanced veterinary care more accessible, boosting overall market value in urban and suburban regions.
• Integration of Digital Technologies and Wearables
  Smart collars, health tracking apps, and telemedicine platforms are being widely adopted in North America. These technologies enable early detection of disease, better post-operative care, and remote consultations, improving clinical outcomes and convenience for owners.
• Rising Demand for Organic and Nutraceutical Pet Products
  In North America, there is growing consumer preference for organic pet food, probiotic supplements, and herbal medications. This trend is being driven by awareness around pet nutrition, preventive care, and side effect reduction from chemical-based products.
• Expansion of Veterinary Clinics and Chain Hospitals
  The number of organized veterinary clinics and multi-location animal hospitals is growing in North America, improving access to care. These clinics offer integrated services like grooming, diagnostics, surgery, and pharmacy enhancing patient retention and service quality.
• Increasing Zoonotic Disease Monitoring and Biosecurity Measures
  Health authorities in North America are implementing surveillance programs to track diseases that affect both animals and humans, such as avian influenza and rabies. This has led to stronger demand for diagnostics, quarantine systems, and biosecurity kits.

Market Growth Drivers

• Rising Livestock Population and Dairy Industry Expansion
  The livestock sector in North America is growing to meet food security and export goals. This expansion drives demand for veterinary pharmaceuticals, vaccines, dewormers, and growth promoters to improve herd productivity and health.
• Government Support for Animal Health Programs
  Public health initiatives in North America include subsidized vaccination drives, disease control schemes, and rural veterinary outreach. These programs expand product adoption in low-income and underserved farming communities.
• Surging Pet Adoption and Urbanization
  In North America, a cultural shift toward nuclear families and urban lifestyles has led to increased pet adoption. Companion animals are viewed as family members, which drives spending on grooming, regular checkups, and specialized dietary needs.
• Growing R&D Investment in Veterinary Pharmaceuticals
  Pharmaceutical companies in North America are investing in development of species-specific drugs, anti-parasitic solutions, and long-acting injectables. Innovations in drug delivery systems are improving treatment compliance and reducing repeat dosages.
• Emergence of Preventive and Holistic Healthcare Models
  There is a shift in North America from reactive veterinary care to preventive approaches. Regular checkups, vaccination schedules, deworming, and wellness monitoring are gaining traction among pet parents and livestock managers.

Challenges in the Market

• Lack of Access to Veterinary Services in Rural Areas
  Veterinary infrastructure in remote parts of North America remains underdeveloped. Shortage of trained professionals, diagnostic equipment, and animal hospitals limits access to timely care, particularly for large animal owners and smallholder farmers.
• Stringent Regulatory Approval Processes
  Bringing new animal drugs and vaccines to market in North America requires extensive regulatory compliance. Approval timelines can delay commercialization, especially for smaller players without global research infrastructure.
• Antibiotic Resistance and Overuse of Veterinary Drugs
  In North America, the unregulated use of antibiotics in livestock farming poses a growing threat. It can lead to drug-resistant pathogens that endanger both animal and human health, requiring tighter oversight and alternative solutions.
• High Cost of Pet Treatments and Limited Insurance Penetration
  Advanced diagnostics and treatments remain expensive in North America. Low penetration of pet insurance means out-of-pocket spending can be a burden for many pet owners, limiting access to quality care.
• Logistical and Cold Chain Challenges for Vaccines
  The effective delivery of veterinary biologics in North America, especially in hot climates or remote regions, is constrained by poor cold chain infrastructure. This affects the potency and shelf life of critical vaccines.

North America Animal Health Market Segmentation

By Animal Type

• Companion Animals
• Dogs
• Cats
• Others (Birds, Rabbits, etc.)
• Livestock Animals
• Cattle
• Poultry
• Pigs
• Sheep & Goats
• Others (Horses, Camels, etc.)

By Product Type

• Pharmaceuticals
• Anti-infectives
• Anti-inflammatory Drugs
• Parasiticides
• Vaccines
• Reproductive Products
• Diagnostics
• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Diagnostic Imaging
• Feed Additives
• Nutritional Feed Additives
• Medicinal Feed Additives
• Medical Devices
• Monitoring Devices
• Surgical Equipment

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Distributors & Wholesalers

By End User

• Veterinary Hospitals & Clinics
• Homecare Settings
• Research Institutes
• Livestock & Poultry Farms

Leading Players

• Zoetis Inc.
• Boehringer Ingelheim Animal Health
• Merck Animal Health
• Elanco Animal Health
• Virbac S.A.
• Ceva Santé Animale
• Vetoquinol S.A.
• IDEXX Laboratories
• Covetrus, Inc.
• Dechra Pharmaceuticals

Recent Developments

• Zoetis Inc. expanded its animal vaccine production facility in North America to meet growing demand for livestock immunization and companion animal health solutions.
• Elanco Animal Health launched a new broad-spectrum parasiticide for cattle and sheep in North America, aiming to enhance farm productivity and reduce disease burden.
• IDEXX Laboratories introduced a new point-of-care diagnostic device in North America for early detection of canine kidney and liver conditions.
• Boehringer Ingelheim partnered with a national veterinary association in North America to train rural veterinarians and improve disease surveillance capacity.
• Virbac announced the acquisition of a local animal nutrition brand in North America to expand its presence in the companion animal feed additive segment.

Other Related Regional Reports Of Animal Health Market